Form 4: Saba Capital Management Sells Shares in abrdn Life Sciences Investors
SEC Form 4 Filing
Saba Capital Management, a 10% owner of abrdn Life Sciences Investors, disposed of 30,156 shares of common stock at a price of $11.14 on April 10, 2025.
Summary
- On April 10, 2025, Saba Capital Management, L.P., disposed of 30,156 shares of common stock of abrdn Life Sciences Investors (HQL).
- The transaction was executed at a price of $11.14 per share.
- Following the transaction, Saba Capital Management, L.P. indirectly owns 3,094,316 shares of HQL.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of a stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. This filing indicates a change in ownership by a major shareholder, Saba Capital Management, L.P.
Key Dates
| Date | Description |
|---|---|
| 04/10/2025 | Date of transaction: Saba Capital Management disposed of shares. |
| 04/14/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Saba Capital Management, abrdn Life Sciences Investors, HQL, Beneficial Ownership, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.